"Lisinopril" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.
Descriptor ID |
D017706
|
MeSH Number(s) |
D12.644.456.345.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lisinopril".
Below are MeSH descriptors whose meaning is more specific than "Lisinopril".
This graph shows the total number of publications written about "Lisinopril" by people in this website by year, and whether "Lisinopril" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lisinopril" by people in Profiles.
-
Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814.
-
Automated Outreach for Cardiovascular-Related Medication Refill Reminders. J Clin Hypertens (Greenwich). 2016 07; 18(7):641-6.
-
Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1173-82.
-
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf. 2010 Mar; 19(3):266-72.
-
Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005 Jun; 27(6):773-81.
-
Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus. Pharmacotherapy. 2003 Dec; 23(12):1564-72.